| Literature DB >> 28025718 |
Emily A Caseley1, Stephen P Muench1, Lin-Hua Jiang2.
Abstract
The P2X7 receptor (P2X7R) is important in mediating a range of physiological functions and pathologies associated with tissue damage and inflammation and represents an attractive therapeutic target. However, in terms of their structure-function relationships, the mammalian P2X7Rs remain poorly characterised compared to some of their other P2XR counterparts. In this study, combining cysteine-based cross-linking and whole-cell patch-clamp recording, we examined six pairs of residues (A44/I331, D48/I331, I58/F311, S60/L320, I75/P177 and K81/V304) located in different parts of the extracellular and transmembrane domains of the human P2X7R. These residues are predicted to undergo substantial movement during the transition of the receptor ion channel from the closed to the open state, predictions which are made based on structural homology models generated from the crystal structures of the zebrafish P2X4R. Our results provide evidence that among the six pairs of cysteine mutants, D48C/I133C and K81C/V304C formed disulphide bonds that impaired the channel gating to support the notion that such conformational changes, particularly those in the outer ends of the transmembrane domains, are critical for human P2X7R activation.Entities:
Keywords: Cross linking; Cysteine substitution; Disulphide bond; Ion channel gating; P2X7 receptor
Mesh:
Substances:
Year: 2016 PMID: 28025718 PMCID: PMC5334206 DOI: 10.1007/s11302-016-9553-0
Source DB: PubMed Journal: Purinergic Signal ISSN: 1573-9538 Impact factor: 3.765
Fig. 1Location of residues in the hP2X7R targeted for cysteine substitution. a Homology model of the hP2X7R with pairs of residues that are subject to examination in this study coloured to correspond with B. b Expanded views of the pairs of residues indicated in A with sidechains indicated and distances between Cβ atoms of the identified pairs in the closed and open states. The closed state is shown on the left panel and the open state on the right. c Representative recording of whole-cell currents induced by 300 μM BzATP from HEK293 cells expressing the wild-type (WT) or indicated single mutant receptors. d Summary of BzATP-induced current amplitude for the WT or single mutant receptors. e Representative recording of whole-cell currents induced by 300 μM BzATP from HEK293 cells expressing the WT or indicated double mutant receptors. f Summary of BzATP-induced current amplitude for the WT or double mutant receptors. *p < 0.05; **p < 0.01; ***p < 0.005 compared to the WT receptor. Three to six cells were recorded in each case
Fig. 2Effects of treatment with DTT on BzATP-induced currents mediated by the WT and single and double cysteine mutant hP2X7Rs. a Representative whole-cell recordings showing BzATP-induced currents prior to, during and after exposure to 10 mM DTT in HEK293 cells expressing the WT or indicated single mutant receptors. b Summary of the effects of DTT treatment on the WT or single mutant receptors by expressing BzATP-induced currents before and at the end of 10-min exposure to DTT as percentage of the mean currents immediately before exposure to DTT. The grey and black columns represent the mean currents in percentage before and 10 min after DTT exposure, respectively. c Representative whole-cell recordings showing BzATP-induced currents prior to, during and after exposure to 10 mM DTT in HEK293 cells expressing the WT or indicated double mutant receptors. d Summary of the effects of DTT treatment on the WT or indicated mutant receptors by expressing BzATP-induced currents at the end of 10-min exposure to DTT as a percentage of the mean currents immediately before exposure to DTT. The grey and black columns represent the mean currents in percentage pre- and post-DTT application, respectively. *p < 0.05. Three to six cells were recorded for each case